IMC-R117C
IMC-R117C-1004
Phase 2 small_molecule active
Quick answer
IMC-R117C for Cancer is a Phase 2 program (small_molecule) at Immunocore Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Immunocore Ireland Limited
- Indication
- Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active